AAUTX
Price
$33.01
Change
+$0.14 (+0.43%)
Updated
Dec 24 closing price
Net Assets
3.24B
VIVAX
Price
$75.23
Change
-$0.04 (-0.05%)
Updated
Dec 26 closing price
Net Assets
215.53B
Interact to see
Advertisement

AAUTX vs VIVAX

Header iconAAUTX vs VIVAX Comparison
Open Charts AAUTX vs VIVAXBanner chart's image
Thrivent Large Cap Value A
Price$33.01
Change+$0.14 (+0.43%)
VolumeN/A
Net Assets3.24B
Vanguard Value Index I
Price$75.23
Change-$0.04 (-0.05%)
VolumeN/A
Net Assets215.53B
AAUTX vs VIVAX Comparison Chart in %
View a ticker or compare two or three
VS
AAUTX vs. VIVAX commentary
Dec 27, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AAUTX is a StrongBuy and VIVAX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VIVAX has more cash in the bank: 216B vs. AAUTX (3.24B). VIVAX pays higher dividends than AAUTX: VIVAX (1.93) vs AAUTX (1.07). AAUTX was incepted earlier than VIVAX: AAUTX (26 years) vs VIVAX (33 years). AAUTX (0.84) is less costly to investors than VIVAX (0.17). AAUTX is a more actively managed with annual turnover of: 29.00 vs. VIVAX (9.00). AAUTX has a lower initial minimum investment than VIVAX: AAUTX (2000) vs VIVAX (3000). AAUTX annual gain was more profitable for investors over the last year : 14.13 vs. VIVAX (12.66). VIVAX return over 5 years is better than : 64.99 vs. AAUTX (51.02).
AAUTXVIVAXAAUTX / VIVAX
Total Expense Ratio0.840.17494%
Annual Report Gross Expense Ratio0.840.17494%
Fund Existence26 years33 years-
Gain YTD15.37914.025110%
Front Load5%N/A-
Min. Initial Investment2000300067%
Min. Initial Investment IRAN/AN/A-
Net Assets3.24B216B2%
Annual Yield % from dividends1.071.9356%
Returns for 1 year14.1312.66112%
Returns for 3 years34.3137.8191%
Returns for 5 years51.0264.9979%
Returns for 10 years95.12134.8671%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
MVISX55.320.23
+0.42%
Patient Opportunity IS
SCIUX12.330.03
+0.24%
Invesco Income Advantage U.S. Fund R5
IEGAX21.230.03
+0.14%
Invesco International Small Company A
LGPSX41.57N/A
N/A
ProFunds Large Cap Growth Svc
LMGTX61.41-0.01
-0.02%
ClearBridge International Growth C